Intriguingly, BIRC5 expression was only associated with significantly more unfavorable PFI in 14/33 cancer types, with 4/14 cancer types (KIRC, LGG, LIHC, and PAAD) after adjusting for both age and tumor grade and 10/14 cancer types (ACC, KICH, KIRP, LUAD, MESO, PCPG, PRAD, SARC, THCA and UVM) after adjusting for age (Fig. 6). Here, BIRC5 is linked to neoplasm.